Surveillance Snapshot: Mid-Season Influenza Vaccine Effectiveness Against Laboratory-Confirmed Ambulatory Influenza Among U.S. Active Component Service Members, December 1, 2024–February 8, 2025

Image of 4CDC_Dan Higgins23224. The months of December through February constitute the period of peak activity for the annual influenza season.

This Surveillance Snapshot provides an overview of the 2024-2025 mid-season analysis of influenza vaccine effectiveness against medically-attended ambulatory influenza infections among active component U.S. service members.

A case test-negative study design was implemented among the population of active component service members from all services who were tested for influenza between December 1, 2024 and February 8, 2025—the period of peak influenza activity for the season. Data from the Defense Medical Surveillance System and standardized laboratory data provided by the Defense Centers for Public Health–Portsmouth were used for this analysis.1 Cases were defined as individuals with a positive influenza result from a rapid antigen, reverse transcription polymerase chain reaction, or culture influenza assay. Test-negative controls were individuals with a negative influenza result from a RT-PCR or culture influenza assay. Crude odds ratios were calculated, and multivariate logistic regression was used to calculate adjusted ORs (adjusted for sex, age category, any influenza vaccination in the previous five years, and month of diagnosis) and 95% confidence intervals. Estimates of VE were defined as (1 – OR) x 100.

There were 4,677 cases (4,413 A any subtype, 389 A[H3N2], 163 A[H1N1]pdm09, 274 B any subtype) and 12,787 TNC. Ten cases were both influenza A- and influenza B-positive. VE varied by influenza type (Table). Adjusted VE estimates for all influenza types and subtypes reached statistical significance. The results indicate moderate mid-season protection against influenza A(H1N1)pdm09 (adjusted VE 41%; 95% CI, 14-60) and A(H3N2) (adjusted VE 50%; 95% CI, 36-60) and low mid-season protection against influenza A (any subtype) (adjusted VE 14%; 95% CI, 5-22) and influenza B (adjusted VE 33%; 95% CI, 9-50).

The results of this analysis show low to moderate mid-season protection of the 2024-2025 seasonal influenza vaccines against medically-attended influenza A and B infections that resulted in an ambulatory care visit among ACSMs. As these estimates were obtained during the middle of the influenza season, VE estimates and confidence intervals may change when data for the full season are available and the sample sizes increase.

Authors’ Affiliation

Epidemiology and Analysis Branch, Armed Forces Health Surveillance Division, Public Health Directorate, Defense Health Agency, Silver Spring, MD: Dr. Cost, Ms. Hu

References 

  1. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health. 2002;92(12):1900-1904. doi:10.2105/ajph.92.12.1900

You also may be interested in...

Topic
Feb 3, 2026

Medical Surveillance Monthly Report

The Medical Surveillance Monthly Report, a peer-reviewed journal launched in 1995, is the Armed Forces Health Surveillance Division's flagship publication. The MSMR provides monthly evidence-based estimates of the incidence, distribution, impact, and trends of health-related conditions among service members.

Report
Dec 1, 2025

MSMR Vol. 32 No. 12 - December 2025

.PDF | 2.90 MB

The December 2025 issue of MSMR features four full reports: the annual update on cold weather injuries among the active and reserve components; a report on trends in the prevalence of obesity among U.S. active component service members and civilians; the annual update on diagnoses of mental health disorders among active component service members; a ...

Article
Dec 1, 2025

Update: Cold weather injuries among the active and reserve components of the U.S. Armed Forces, July 2020–June 2025

Since 2004, MSMR has published annual updates on the incidence of cold weather injuries affecting U.S. Armed Forces members for the five most recent cold seasons. This 2025 report discusses the occurrence of frostbite, immersion hand and foot injuries, hypothermia, as well as “other specified and unspecified effects of reduced temperature.”

Report
Nov 1, 2025

MSMR Vol. 32 No. 11 - November 2025

.PDF | 3.56 MB

The November 2025 MSMR presents four full reports on sexually transmitted infections (STIs), led by the annual update on STIs among active component service members, 2016–2024; followed by a report on follow up testing for chlamydia or gonorrhea among male Air Force basic trainees, 2017–2023; accompanied by a report on sexual networks of service ...

Report
Oct 1, 2025

MSMR Vol. 32 No. 10 - October 2025

.PDF | 2.90 MB

The October 2025 MSMR presents five full reports: measles, mumps, rubella and varicella within the Military Health System; seasonal influenza hospitalization among service members; BMI, physical fitness, and COVID-19 hospitalization in the Army; adverse pregnancy outcomes in female service members after COVID-19 infection or vaccination; long COVID ...

Refine your search